Droxidopa Capsule
Product Images NDC 0904-7394

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Droxidopa (NDC 0904-7394). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Droxidop-capsules100-mg-90s-label (Droxidop Capsules100 mg 90s Label)

Droxidop-capsules100-mg-90s-label (Droxidop Capsules100 mg 90s Label)
This text appears to be a description of a medication called Droxidopa Capsules. Each capsule contains 100 mg of droxidopa. The usual dosage and other important information can be found in the prescribing information. The capsules should be stored at a temperature between 20°C to 25°C (68°F to 77°F), with permitted excursions to 15°C to 30°C (59°F to 86°F). The medication should be dispensed in a tight and light-resistant container. It is important not to use the capsules if the printed seal under the cap is broken or missing. A warning is given to keep the medication out of reach of children. The medication is manufactured by MSN Pharmaceuticals Inc. and distributed by MAJOR® PHARMACEUTICALS in Indianapolis, IN, USA. Unfortunately, no specific details about the medication's purpose or indications are available in the given text.*
FDA Label Image

Droxidop-capsules200-mg-90s-label (Droxidop Capsules200 mg 90s Label)

Droxidop-capsules200-mg-90s-label (Droxidop Capsules200 mg 90s Label)
Description: This text appears to be the label of a medication called Droxidopa Capsules. Each capsule contains 200 mg of droxidopa. The text provides information on the usual dosage, storage instructions, and warnings. The medication is manufactured by MSN Pharmaceuticals Inc. and distributed by MAJOR® PHARMACEUTICALS.*
FDA Label Image

Droxidop-capsules300-mg-90s-label (Droxidop Capsules300 mg 90s Label)

Droxidop-capsules300-mg-90s-label (Droxidop Capsules300 mg 90s Label)
This is a description for a medication called Droxidopa Capsules. Each capsule contains 300 mg of the active ingredient droxidopa. The usual dosage can be found in the prescribing information. The medication should be stored between 20°C to 25°C (68°F to 77°F), with permissible excursions to 15°C to 30°C (59°F to 86°F). It should be kept in a tight, light-resistant container. The medication should not be used if the printed seal under the cap is broken or missing. There is a warning to keep the medication out of reach of children. The medication is manufactured by MSN Pharmaceuticals Inc. and distributed by Major Pharmaceuticals. For more information, you can visit the website majorpharmaceuticals.com.*
FDA Label Image

Figure-2 (Droxidopa Figre 02)

FDA Label Image

Figure-01 (Droxidopa Figure 01)

FDA Label Image

Structure (Droxidopa Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.